PharosAI

Imagine a future where AI technology is routinely embedded in your R&D and cancer clinical workflows, bringing new discoveries, diagnostics and treatment and clinical decision support to the fore with speed and precision. PharosAI is a platform to navigate the path to AI-assisted healthcare within the NHS, built on a consortium across King’s College London, Guy’s and St Thomas Foundation Trusts, Barts Cancer Institute and Barts Health Trust, together with NHS England, UK Biobank, Royal College of Pathologists, and industry. PharosAI will build unique, high quality and enriched patients’ datasets with significant clinical plurality and educate the workforce with the knowledge and skills to maximise the benefits of this AI-enabled future and will significantly accelerate the UK’s vision to deliver the right treatment, at the right time, for all patients regardless of their socioeconomic background.